Aims: Nicorandil, an ATP sensitive potassium channel opener, may reduce the incidence of
microvascular dysfunction after percutaneous coronary intervention (PCI) by dilating …

Background: Although microvascular dysfunction following percutaneous coronary
intervention (PCI) can be evaluated with the index of microcirculatory resistance (IMR), no …

Purpose In patients undergoing primary percutaneous coronary intervention (PCI) for the
treatment of ST-segment elevation myocardial infarction (STEMI), coronary microvascular …

Background Nicorandil, as a selective potassium channel opener, has dual action including
coronary and peripheral vasodilatation and cardioprotective effect through ischemic …

OBJECTIVE: The Impact of Nicorandil in Angina (IONA) trial demonstrated that the use of
nicorandil, an anti-anginal drug, reduced future cardiovascular events in patients with stable …

Background Using the current meta-analysis as well as systematic review, to determine the
curative effect of Nicorandil in comparison of no Nicorandil after elective percutaneous …

Background To determine whether nicorandil administration distal to the thrombus in the
coronary artery during percutaneous coronary intervention (PCI) in acute ST-segment …

Background Intravenous nicorandil infusion dilates the coronary artery and reduces
inflammation, coronary spasm, and arrhythmia. Periprocedural myocardial infarction (PMI) is …

Objective: Currently, there is still no effective strategy to diminish the infarct size (IS) in
patients with ST-segment elevation myocardial infarction (STEMI). According to a previous …

Background The purpose of the study was to prospectively evaluate the protective effect of
nicorandil during percutaneous coronary intervention (PCI) in patients with unstable angina …